东莞药品医疗商户画像数据集

一、药品医疗上下游企业优化合作策略 （RFM-C 模型） 医药批发商对 VIP 级商户（R=5 分、F=5 分、M=4 分、C=5 分），依高 M/C 评分的大额采购需求签年度协议，给 5%-8% 批量折扣，借高 R 评分的高频特征开通 24 小时配送通道；对重点级商户（M是2-3 分、C是3-4 分），推 “成长方案”—— 季度采购达标后赠效期管理培训、库存预警系统；对一般级商户，分析低评分原因（如 R 低为淡季、F 低为客流少），提供小额试购、医保支付指导，培育稳定合作。 二、行业研究机构开展产业分层研究（RFM-C 模型） 追踪 VIP 商户数量与评分波动，若 90% VIP 的 R是4-5 分、F是5 分，可印证头部商户经营稳定；对比重点与 VIP 商户，发现重点多在 M 评分差 5-10 万元，得出 “扩采购规模是进阶关键”；研究一般商户，若 70% R是1 分、F小于等于2 分，提示中小商户经营压力，为政府制定补贴、协会开展培训、企业调整策略提供数据支撑。

1. Optimized Cooperation Strategy for Upstream and Downstream Pharmaceutical and Medical Enterprises (RFM-C Model)
For pharmaceutical wholesalers, annual cooperation agreements shall be signed with VIP-level merchants (with scores R=5, F=5, M=4, C=5) based on their large procurement demands with high M/C score ratios, providing a 5%-8% bulk discount; 24-hour delivery channels shall be opened leveraging the high-frequency characteristic of their high R scores. For key-level merchants (with M scores of 2-3 and C scores of 3-4), a "Growth Program" shall be launched: merchants that meet quarterly procurement targets will receive free expiry date management training and inventory early warning systems. For general-level merchants, analyze the causes of their low scores (e.g., low R score due to off-season, low F score due to insufficient customer flow), provide small-volume trial orders and medical insurance payment guidance to foster stable cooperation.

2. Industrial Stratification Research Conducted by Industry Research Institutions (RFM-C Model)
Track the number of VIP merchants and fluctuations in their scores. If 90% of VIP merchants have R scores of 4-5 and F scores of 5, it can confirm that leading merchants operate stably. By comparing key-level and VIP merchants, it is found that the M score gap between most key-level merchants and VIP merchants is 50,000 to 100,000 yuan, leading to the conclusion that "expanding procurement scale is the key to advancement". When studying general merchants, if 70% of them have R scores of 1 and F scores ≤2, it indicates operating pressure on small and medium-sized merchants, providing data support for government subsidy formulation, industry association training activities, and enterprise strategy adjustment.

搜集汇总

背景与挑战

背景概述

该数据集聚焦东莞药品医疗领域商户，通过RFM-C模型整合交易金额、笔数、分润等关键信息，构建商户全景画像以支持价值评估。数据已脱敏处理，格式为Xlsx，应用于商户分级、合作策略优化和服务响应提速等场景，赋能精细化运营决策。